Miconazole warnings and precautions

Revision as of 08:59, 9 January 2014 by Ahmed Zaghw (talk | contribs)
Jump to navigation Jump to search
Miconazole
Oravig® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]

Warnings and Precautions

Hypersensitivity

Allergic reactions, including anaphylactic reactions and hypersensitivity, have been reported with the administration of miconazole products, including ORAVIG.

Discontinue ORAVIG immediately at the first sign of hypersensitivity.

There is no information regarding cross-hypersensitivity between miconazole and other azole antifungal agents.

Monitor patients with a history of hypersensitivity to azoles.[1]

References

  1. "ORAVIG (MICONAZOLE) TABLET [PRAELIA PHARMACEUTICALS INC]".

Adapted from the FDA Package Insert.